NewsSource: EClinCloud

Invitation | Knowledge Graph Technology in Intelligent Clinical Research — dTrial

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: eClinCloud.


Click the blue text above to follow us

Article illustration


Last year, DIA hosted the first Digital Clinical Trial Innovation Forum, focusing closely on two key themes—clinical research informatization and remote intelligent clinical trials—and presenting a panoramic view of advances and practices in informatization, intelligence, remote execution, and integration in clinical research.

This year, on April 16–17, DIA will hold the 2nd Digital Clinical Trial Innovation Forum (dTrial Forum) to share practical digital clinical experience. As a pioneer in digital clinical trials in China, EClinCloud has once again been invited to participate, with CTO Mr. Wu Weiping sharing his experience—cutting-edge content not to be missed.


Article illustration
Wu Weiping
CTO, EClinCloud


  • Over 30 years of experience in IT technology, having held leadership positions across various departments—including sales, pre-sales, and services—at multiple multinational technology companies;

  • Before joining EClinCloud, he served as CTO for China at Hitachi Vantara and is an expert in IT infrastructure, SaaS platform services, data storage, and security;

  • Prior to Hitachi, he worked at Oracle for nearly 9 years as General Manager of the Life Sciences Business Unit (HSGBU) and the Financial Services Business Unit, and was among the first in China to promote clinical research software systems such as OC/RDC, InForm, Siebel CTMS, and Argus;

  • Previously worked at IBM for 8 years as Director of Solutions and Services, covering the financial, biopharmaceutical, and manufacturing industries.




Conference Information



Article illustration

Date: April 16–17

Venue: Renaissance Shanghai Caohejing Hotel




Subforum 3: Emerging Technologies in Clinical Research (Technical Track)

Artificial Intelligence and Natural Language Processing


Time: Friday, April 16, 13:30–15:00

Venue: Renaissance Shanghai Caohejing Hotel, 2F, Ballroom III

Topic: Knowledge Graph Technology in Intelligent Clinical Research Practice

Speaker: Wu Weiping, CTO, EClinCloud


Article illustration


EClinCloud looks forward to seeing you at dTrial!




EClinCloud

EClinCloud aims to build a leading clinical research cloud platform. Guided by the mission of "bringing effective treatments to patients through technological innovation," it is a healthcare and life sciences technology company based in China and serving the world.
EClinCloud's clinical research cloud platform is an independently developed, end-to-end, seamlessly integrated unified platform, including electronic informed consent (eConsent), electronic data capture (EDC), randomization and trial supply management (RTSM), electronic clinical outcome assessment (eCOA), clinical trial management system (CTMS), electronic trial master file (eTMF), risk-based monitoring (RBM), and virtual clinical trials (Virtual Trial). Through EClinCloud's specialized solutions, it helps pharmaceutical companies, medical device companies, and research institutions accelerate new drug R&D, reduce clinical research costs, and lower clinical research risks.
Article illustration

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.